Long-term use of repeated doses of dalbavancin as prophylaxis for recurrent Gram-positive bacteraemic cellulitis

Clin Microbiol Infect. 2020 Mar;26(3):386-387. doi: 10.1016/j.cmi.2019.10.010. Epub 2019 Oct 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / pharmacokinetics
  • Cellulitis / microbiology*
  • Cellulitis / prevention & control*
  • Disease Management
  • Duration of Therapy*
  • Gram-Positive Bacterial Infections / prevention & control*
  • Humans
  • Teicoplanin / administration & dosage
  • Teicoplanin / analogs & derivatives*
  • Teicoplanin / pharmacokinetics
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Teicoplanin
  • dalbavancin